Biopharma startups face significant challenges when transitioning from lab discoveries to full-scale drug production. In this recent Pharmaceutical Processing World article, Business Leaders Scott Courtney, AIA, LEED AP BD+C and Greg Verhoff, LEED AP, discuss what areas to focus on to successfully navigate this transition.
Scott has been with SSOE since 2018 and has 30 years of expertise in architecture, with over two decades of that time focused on national and international GMP-compliant pharmaceutical environments design. Over his many years designing these facilities, Scott has learned and embraced the changes that have evolved in the market, while incorporating state-of-the-art features.
Greg has been with SSOE since 2014 and has nearly two decades of experience serving in the roles of construction manager, facility manager, and A/E project manager. His leadership provides a unique perspective that ensures SSOE’s design approach is achievable, maintainable, and cost-effective. His experience also includes serving as the architectural space planner and site master planner for a large pharmaceutical campus.
To read the full article, click here.
